A federal Government commitment to the National Strategic Action Plan developed by MDFA is recognition of the enormous impact macular disease has in our society.
Read MoreA federal Government commitment to the National Strategic Action Plan developed by MDFA is recognition of the enormous impact macular disease has in our society.
Read MoreResearch shows statin use could be linked to lower rates of diabetic retinopathy.
Read MoreUp to a quarter of anti-VEGF patients being treated for AMD and diabetic macular oedema are lost to follow-up.
Read MoreA change to the Pharmaceutical Benefits Scheme listing for two key medicines, is a “big win for the macular disease community”.
Read MoreThe federal today announced funding for MDFA to develop a Strategic National Action Plan for Macular Disease.
Read MoreSurvey results released for Macula Month highlight the need for Australians, particularly those living with diabetes, to be more aware of macular disease.
Read MoreMDFA supports calls for the Commonwealth Bank to stop the roll out of touchscreen EFTPOS machines until accessibility issues are fixed.
Read MoreMDFA’s Low Vision report highlights the evidence base supporting the benefits of aids and technologies for those with vision loss and blindness.
Read MorePeople living in rural and remote areas needing sight-saving treatment will benefit from an important procedural change.
Read More